期刊文献+

低分子肝素对脓毒症大鼠急性肺损伤的保护作用 被引量:9

Protective effect of low molecular weight heparin on acute lung injury in sepsis rats
暂未订购
导出
摘要 目的探讨低分子肝素对脓毒症大鼠肺组织高迁移率族蛋白B1(HMGB-1)的影响以及对由大鼠盲肠结扎穿孔(CLP)所致的急性肺损伤的保护作用。方法144只SPF级雄性sD大鼠(体质量200~220g)被随机分为假手术组(48只)、盲肠结扎穿孔术(CLP)后常规治疗组(48只)及常规加低分子肝素治疗组(48只),分别施以假手术(A组)或CLP(B组和C组)。术后各组立即腹腔注射生理盐水(NS)2mL及头孢曲松(30mg/kg)、C组加用低分子肝素10U(50U/kg)。以术后3、6、12、18、24、48h为观察点,观察各组大鼠术后活动、进食、竖毛、腹泻、眼球凹陷、呼吸等情况;活杀并行脓毒症大鼠评分及观察死亡率、肺湿干质量比(W/D)及病理学变化。采用逆转录-聚合酶链反应(RT—PCR)技术测肺组织HMGB-1mRNA的表达;采用Westernblot法检测肺组织HMGB-1蛋白的表达。结果注射低分子肝素(达肝素钠)(50U/kg)的脓毒症大鼠死亡率及肺部高迁移率族蛋白-1的蛋白表达及其mRNA的表达与对照组比较均明显降低(P〈0.05),低分子肝素干预组中脓毒症大鼠评分及肺湿干比、病理损害均减少。结论低分子肝素能够抑制CLP引起的脓毒症过程中的晚期炎症介质释放,改善CLP模型(严重腹腔感染)引起的急性肺损伤过程中的肺干湿质量比、病理改变及死亡率。本实验推测这种作用是通过低分子肝素对炎症引起的肺损伤中凝血一炎症轴的影响而实现的。 Objective To observe the influence of low molecular weight heparin on systemic inflammation, including high mobility group box 1 protern ( HMGB - 1 )and protective effect on acute lung injuty induced by cecal ligation and puncture(CLP). Discuss the mechanism of this effect. Methods A sepsis model reproduced by CLP, and 144 male SD rats were randomly divided into normal control (A), CLP group ( B), the LMWH treatment group ( C ), n = 48. Inject saline and ceftriaxone ( B, C ) or LMWH(C) once after operation. Observe points were made at 3,6, 12, 18,24,48 h, the rats were anesthesized and killed, mortality, lungs wet/dry ratio and Pathology change were determined. HMGB - 1 mRNA and protein of lung tissues were calculated by RT - PCR and Western blot. TNF -α and IL - 6 of blood plasma calculated by ELISA. Results There was significantly in each index between CLP group and control group( P 〈 0. 05 ). Compared with CLP group, there was a markly decrease in lung wet/dry ratio, the mortality and HMGB - 1 mRNA and ptotein expression on lung tissues ( P 〈 0.05 ). The lung injury has decresed in LMWH group compared with CLP group. Conclusion LMWH can decreases cytokin-e and HMGB -1 levels during CLP -induced inflammation. As a result, LMWH ameli - orated lungpathology and reduces mortality in CLP - induced systemicinflammation in a rat model. This effect may be mediated through the inhibition of axis of inflammation and coagulation.
出处 《中国急救医学》 CAS CSCD 北大核心 2010年第8期720-724,I0001,共6页 Chinese Journal of Critical Care Medicine
基金 上海市重点学科建设基金(No.08GW2X1103)
关键词 高迁移率族蛋白B1 低分子肝素 脓毒症 急性肺损伤 HMGB - 1 Low molecular weight heparin Sepsis Acute lung Injury
  • 相关文献

参考文献14

  • 1lto T, Kawahara K, Nakamura T, et al. High - mobility group box 1 protein promotes development ofmicrovascular thrombosis in mts[ J]. J Thromb Haemost, 2007,5 ( 1 ) : 109 - 116.
  • 2Wang H, Yang H, Czura C J, et al. HMGB - 1 as a late mediator of lethal systemic inflammation[J]. Am J Respir Crit Care Med, 2001, 164(10) : 1768 - 1773.
  • 3Schultz M J, Haitsma J J, Zhang H, et al. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia- a review[J]. Crit Care Med, 2006,34(3) :871 -877.
  • 4Feistritzer C, Wiedermann CJ. Effects of anticoagulant strategieson activation of inflammation and coagulation [ J ]. Expert Opin Biol Ther, 2007, 7 (6) :855 - 870.
  • 5邵义明,姚华国,梁小仲,夏炎火.高迁移率族蛋白B1表达水平与大鼠脓毒症严重程度及预后关系的实验研究[J].中国危重病急救医学,2006,18(11):668-672. 被引量:54
  • 6Agarwal R, Gupta D. Anticoagulation in sepsis: is low -dose heparin as effective as activated protein C[ J] . Intensive Care Med ,2005, 31 (9) : 1297 - 1298.
  • 7Wang HC, Zhu S, Zhou RR,et al. Therapeutic potential of HMGB- 1 targeting agents in sepsis[J]. Expert Rev Mol Med, 20-,10: e32.
  • 8Alessandra Bitto, Mario Barone, Polito F, et al. High mobility group box - 1 expression correlates with poor outcome in lunginjury patients [ J ]. Pharmacological Research, 2010,61 (2) : 116 - 120.
  • 9凌燕,王春友,杨智勇.肝素与高迁移率族蛋白1相互作用的光谱研究[J].分析测试学报,2009,28(2):146-149. 被引量:1
  • 10Fan J, Li YH, Vodovotz Y, et al. Hemorrhagic shock - activated neutrophils augment TLR4 signaling - induced TLR2 up regulation in alveolar macrophages : role in hemorrhage - primed lung inflammation[J]. Am J Physiol Lung Cell Mol Physiol, 2006,290(4) :738 - 746.

二级参考文献32

共引文献95

同被引文献85

  • 1祁峰,陈建荣,徐志华,曹亮.低分子肝素治疗脓毒症急性肺损伤/急性呼吸窘迫综合征的临床研究[J].中国血液流变学杂志,2014(1):71-76. 被引量:15
  • 2艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 3张晓娟,马晓春.重症感染患者早期应用小剂量肝素治疗的临床研究[J].中华外科杂志,2006,44(17):1209-1211. 被引量:11
  • 4邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 5Slofstra SH, Van't Veer C, Buurman WA, et al. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation [ J ]. Cl-it Care Med ,2005,33 ( 6 ) : 1365-1370.
  • 6Wiedemann CJ,Hoffmann JN,Juers M, et al. High-dose an- tithrombin 111 in the treatment of severe sepsis in patients with a high risk of death:efficacy all safety [ J ]. Crit Care Med, 2006,34 ( 2 ) : 285-292.
  • 7Zarychanski R, Doucette S, Fergusson D, et al. Early intrave- nous unfractionated heparin and mortality in septic shock [ J ]. Crit Care Med,2008,36 ( 11 ) :2973-2979.
  • 8Jaimes F, De La Rosa G, Morales C, et al. Unfractioned hepa- fin for treatment of sepsis:A randomized clinical trial (The HETRASE Study) E J 1. Crit Care Med, 2009,37 ( 4 ) : 1185- 1196.
  • 9吴孟超,吴在德,吴肇汉主编.外科学.第8版.北京:人民卫生出版社.2013.140.
  • 10姚金国.急性腹膜炎的鉴别诊断.中外健康文摘,2011,6:26-27.

引证文献9

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部